Novel Approaches to Advanced Breast Cancer: Bevacizumab and Lapatinib

Author： Mayer Erica L. Lin Nancy U. Burstein Harold J.

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.5, Iss.3, 2007-03, pp. : 314-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is it worth using lapatinib for advanced breast cancer?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Lapatinib: A Review of its Use in the Treatment of HER2-Overexpressing, Trastuzumab-Refractory, Advanced or Metastatic Breast Cancer

By Frampton James E.

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2125-2148

Adis International

Access to resources Recommend Favorite

Novel pharmacological approaches in the treatment of breast cancer

By Nahta Rita Hortobagyi Gabriel N Esteva Francisco J

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 6, 2003-06 ,pp. : 909-921

Informa Healthcare

Access to resources Recommend Favorite

Lapatinib for breast cancer: a review of the current literature

By MacFarlane Robyn J Gelmon Karen A

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 109-121

Informa Healthcare

Access to resources Recommend Favorite

Lapatinib no help in HER-2-negative breast cancer

Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite